^
Association details:
Biomarker:miR-18a overexpression
Cancer:Colorectal Cancer
Regimen:FOLFOX
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: C3 – Early Trials
Title:

Protective effect of miR-18a in resected liver metastases of colorectal cancer and FOLFOX treatment

Published date:
09/12/2023
Excerpt:
Patients with a high miR-18a expression in liver metastases had a progression-free survival (PFS) of 13.6 months versus 8.9 months in patients with low expression (N = 123; p = .024)….High expression of miR-18a in colorectal liver metastases might have a protective effect after resection of metastases and FOLFOX treatment regarding PFS.
DOI:
https://doi.org/10.1002/cnr2.1899